Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents. However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on adenosine triphosphate (ATP) and is associated with multidrug resistance. Complementary DNA (cDNA) clones corresponding to messenger RNAs (mRNAs) overexpressed in H69AR cells were isolated. One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells. Overexpression was associated with amplification of the cognate gene located on chromosome 16 at band p13.1. Reversion to drug sensitivity was associated with loss of gene amplification and a marked decrease in mRNA expression. The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overexpression of ABCC1 in tumor cells has been implicated in the multidrug-resistant phenotype caused by cytotoxic drugs (60).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“ABCC1, which was originally cloned from the human small cell lung cancer cell line H69AR (60), is known to transport a variety of endogenous substrates, such as the antioxidant glutathione and pro-inflammatory leukotrienes (65).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“To date, at least 15 human ABC superfamily transporters, including ABCB1 (59), ABCC1 (60), and ABCG2 (61), have been reported to mediate multidrug resistance in different circumstances, including G12Ci treatment (27, 62, 63).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Progressive sequence alignment as a prerequisitetto correct phylogenetic trees
Feng, D.-F., & Doolittle, R. F. (1987) · Journal of Molecular Evolution · doi:10.1007/bf02603120 · Cited by 1,883
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Research works printed but not linked: 3
- GERLACH, J.H., MULTIDRUG RESISTANCE, CANCER SURVEYS 5: 25 (1986).
- UEYAMA, H, STRUCTURE OF A HUMAN SMOOTH-MUSCLE ACTIN GENE (AORTIC TYPE) WITH A UNIQUE INTRON SITE, MOLECULAR AND CELLULAR BIOLOGY 4: 1073 (1984).
- VANDERBLIEK, A.M., OVEREXPRESSION AND AMPLIFICATION OF 5 GENES IN A MULTIDRUG-RESISTANT CHINESE-HAMSTER OVARY CELL-LINE, MOLECULAR AND CELLULAR BIOLOGY 6: 1671 (1986).
Cited by
Items 101–200 of 1,012
Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.
Hooijberg, J. H., Broxterman, H. J., Kool, M., Assaraf, Y. G., Peters, G. J., Noordhuis, P., Scheper, R. J., Borst, P., Pinedo, H. M., & Jansen, G. (1999) · PubMed · Cited by 497
Matsuo, H., Takada, T., Ichida, K., Nakamura, T., Nakayama, A., Ikebuchi, Y., Ito, K., Kusanagi, Y., Chiba, T., Tadokoro, S., et al. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000237 · Cited by 437
Wijnholds, J., Evers, R., van Leusden, M. R., Mol, C. A. A. M., Zaman, G. J. R., Mayer, U., Beijnen, J. H., Valk, M. V. D., Krimpenfort, P., & Borst, P. (1997) · Nature Medicine · doi:10.1038/nm1197-1275 · Cited by 432
ABC Transporters, Drug Resistance, and Cancer Stem Cells
Dean, M. (2009) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-009-9109-9 · Cited by 425
“However there are two other ABC proteins widely overexpressed in tumor cells, ABCC1/MRP1 [19] and ABCG2 [20–23].”
BackgroundABC transporters as mediators of drug resistance and contributors to cancer cell biology
Fletcher, J. I., Williams, R. T., Henderson, M. J., Norris, M. D., & Haber, M. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.03.001 · Cited by 423
Choudhuri, S., & Klaassen, C. D. (2006) · International Journal of Toxicology · doi:10.1080/10915810600746023 · Cited by 415
“Its levels are relatively high in lung, testes, and kidney and it is also expressed in several blood-organ barrier contributing to protected sites (Cole et al. 1992; Borst et al. 1999, 2000).”
BackgroundChemotherapy With Focal Therapy Can Cure Intraocular Retinoblastoma Without Radiotherapy
Gallie, B. L. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140521001 · Cited by 416
Structural, mechanistic and clinical aspects of MRP1
Hipfner, D. R., Deeley, R. G., & Cole, S. P. C. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00168-6 · Cited by 412
Self-citationInhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment: Miniperspective
Waghray, D., & Zhang, Q. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01457 · Cited by 400
An overview of cancer multidrug resistance: a still unsolved problem
Lage, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8111-5 · Cited by 408
Mechanisms and strategies to overcome multiple drug resistance in cancer
Ozben, T. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.020 · Cited by 406
“In 1992, Susan Cole and Roger Deeley observed amplification and increased expression of a novel gene, the MRP1 (ABCC1) (MDR related protein) gene in a non-P-gp MDR cell line, namely a small-cell lung carcinoma cell line [10,18].”
BackgroundMolecular and Cellular Physiology of Renal Organic Cation and Anion Transport
Wright, S. H., & Dantzler, W. H. (2004) · Physiological Reviews · doi:10.1152/physrev.00040.2003 · Cited by 404
“First cloned from multidrug resistant human lung cancer cells in 1992 (71), MRP1 (ABCC1) is broadly expressed in many cells types (66, 225), with the highest expression generally found in the basolateral membrane of epithelial cells (241).”
BackgroundVitamin B12 transport from food to the body's cells—a sophisticated, multistep pathway
Nielsen, M. J., Rasmussen, M. R., Andersen, C. B. F., Nexø, E., & Moestrup, S. K. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.76 · Cited by 403
Kartenbeck, J., Leuschner, U., Mayer, R., & Keppler, D. (1996) · Hepatology · doi:10.1002/hep.510230519 · Cited by 398
Transport of Cyclic Nucleotides and Estradiol 17-β-d-Glucuronide by Multidrug Resistance Protein 4
Chen, Z.-S., Lee, K., & Kruh, G. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104833200 · Cited by 396
The apical conjugate efflux pump ABCC2 (MRP2)
Nies, A. T., & Keppler, D. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0109-y · Cited by 398
“[21], 2 years before the identification of the first transport substrates of ABCC1 [105, 120].”
BackgroundMethodResultMultixenobiotic resistance as a cellular defense mechanism in aquatic organisms
Bard, S. (2000) · Aquatic Toxicology · doi:10.1016/s0166-445x(00)00088-6 · Cited by 392
ABCG2: determining its relevance in clinical drug resistance
Robey, R. W., Polgar, O., Deeken, J., To, K. W., & Bates, S. E. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9042-6 · Cited by 387
“In 1993, Cole and colleagues cloned a gene encoding another energy-dependent transporter, the multidrug resistance-associated protein, or MRP1 (ABCC1) [5].”
BackgroundMultidrug resistance transporters and modulation
Tan, B., Piwnica-Worms, D., & Ratner, L. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200009000-00011 · Cited by 384
Beck, W. T., Grogan, T. M., Willman, C. L., Cordon‐Cardo, C., Parham, D. M., Kuttesch, J. F., Andreeff, M., Bates, S. E., Berard, C. W., Boyett, J. M., et al. (1996) · PubMed · Cited by 384
Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters
Leslie, E. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00454-1 · Cited by 376
Structural Basis of Substrate Recognition by the Multidrug Resistance Protein MRP1
Johnson, Z. L., & Chen, J. (2017) · Cell · doi:10.1016/j.cell.2017.01.041 · Cited by 375
“MRP1, also known as ABCC1, was first identified in 1992 from drug-resistant lung cancer cells that did not express P-gp (Cole et al., 1992).”
Glutathione-Depleting Nanomedicines for Synergistic Cancer Therapy
Cheng, X., Xu, H.-D., Ran, H.-H., Liang, G., & Wu, F.-G. (2021) · ACS Nano · doi:10.1021/acsnano.1c00498 · Cited by 374
Persidis, A. (1999) · Nature Biotechnology · doi:10.1038/5289 · Cited by 372
Superoxide dismutases in malignant cells and human tumors
Kinnula, V. L., & Crapo, J. D. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.12.010 · Cited by 373
Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma
Sarkaria, J. N., Kitange, G. J., James, C. D., Plummer, R., Calvert, H., Weller, M., & Wick, W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1719 · Cited by 373
“The two transporters commonly associated with drug resistance in cancer cells are the MDR1 gene products P-glycoprotein and the multidrug resistance-associated protein (45).”
BackgroundCell biological mechanisms of multidrug resistance in tumors.
Simon, S. M., & Schindler, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3497 · Cited by 369
Transport of glutathione and glutathione conjugates by MRP1
Cole, S. P. C., & Deeley, R. G. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.06.008 · Cited by 369
Self-citationResistance mechanisms associated with altered intracellular distribution of anticancer agents
Larsen, A. K., Escargueil, A. E., & Skladanowski, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00073-x · Cited by 369
Szczypka, M. S., Wemmie, J. A., Moye-Rowley, W. S., & Thiele, D. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31723-4 · Cited by 367
Biology of the multidrug resistance-associated protein, MRP
Loe, D. W., Deeley, R. G., & Cole, S. P. C. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00046-9 · Cited by 367
Self-citationCole, S. P. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.609248 · Cited by 361
“In MRP1, the TMs of MSD1 and MSD2 contain a higher frequency of polar amino acids than do the analogous TMs of P-glycoprotein.”
BackgroundInfluentialSelf-citationMeier, P. J., Eckhardt, U., Schroeder, A., Hagenbuch, B., & Stieger, B. (1997) · Hepatology · doi:10.1002/hep.510260641 · Cited by 362
Wijnholds, J., de Lange, E. C. M., Scheffer, G. L., van den Berg, D.-J., Mol, C. A. A. M., van der Valk, M., Schinkel, A. H., Scheper, R. J., Breimer, D. D., & Borst, P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8267 · Cited by 360
Kool, M., van der Linden, M., de Haas, M., Baas, F., & Borst, P. (1999) · PubMed · Cited by 414
Flavonoids Are Inhibitors of Breast Cancer Resistance Protein (ABCG2)-Mediated Transport
Zhang, S., Yang, X., & Morris, M. E. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1208 · Cited by 359
“MCF-7/sensitive and MCF-7/Adr cells were used as the negative and positive control for P-gp (Fairchild et al., 1990); H69 and H69/AR cells were used as the negative and positive control for MRP1 (Cole et al., 1992).”
BackgroundMethodInfluentialDrug Transporters in Drug Efficacy and Toxicity
DeGorter, M. K., Xia, C. Q., Yang, J. J., & Kim, R. B. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134529 · Cited by 359
“As it became apparent that P-glycoprotein was not the only molecule capable of conferring a multidrug-resistant phenotype, two other ABC transporters involved in multidrug resistance were cloned: multidrug resistance-associated protein 1 (MRP1/ABCC1) (132) and breast cancer resistance protein (BCRP/ABCG2) (133–135).”
BackgroundExpression and function of efflux drug transporters in the intestine
Takano, M., Yumoto, R., & Murakami, T. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.005 · Cited by 356
Strategies for reversing drug resistance
Fojo, T., & Bates, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206951 · Cited by 357
“The first of these to be identified, the multidrug resistance-associated protein 1 (MRP1 or ABCC1) is similar to Pgp in several respects (Cole et al., 1992).”
BackgroundROLE OF ABCG2/BCRP IN BIOLOGY AND MEDICINE
Krishnamurthy, P., & Schuetz, J. D. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141238 · Cited by 356
Overview: ABC Transporters and Human Disease
Gottesman, M. M., & Ambudkar, S. V. (2001) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1012866803188 · Cited by 350
Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs
Cascorbi, I. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.009 · Cited by 355
Allen, J. D., Brinkhuis, R. F., Wijnholds, J., & Schinkel, A. H. (1999) · PubMed · Cited by 403
Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer
Coley, H. M. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.01.007 · Cited by 351
Ross, D. D., Yang, W., Abruzzo, L. V., Dalton, W. S., Schneider, E., Lage, H., Dietel, M., Greenberger, L., Cole, S. P. C., & Doyle, L. A. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.5.429 · Cited by 350
Self-citationMultidrug resistance mediated by the ATP-binding cassette transporter protein MRP
Cole, S. P. C., & Deeley, R. G. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199811)20:11<879::aid-bies2>3.0.co;2-i · Cited by 344
Self-citationMultidrug resistance mediated by the ATP-binding cassette transporter protein MRP
Cole, S. P. C., & Deeley, R. G. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199811)20:11<931::aid-bies8>3.0.co;2-j · Cited by 342
Self-citationAccumulation of Glucosylceramides in Multidrug-resistant Cancer Cells
Lavie, Y., Cao, H.-T., Bursten, S. L., Giuliano, A. E., & Cabot, M. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19530 · Cited by 340
Strunnikov, A. V., Hogan, E., & Koshland, D. (1995) · Genes & Development · doi:10.1101/gad.9.5.587 · Cited by 339
Molecular basis of antifolate resistance
Assaraf, Y. G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9049-z · Cited by 338
“MRP1, the first member of the MRP family to be discovered is a ∼190 kDa N-glycosylated transmembrane protein [74].”
BackgroundLubelski, J., Konings, W. N., & Driessen, A. J. M. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00001-07 · Cited by 339
“Distribution of MDR Transporters Historically, the first cloned and characterized MDR transporters were members of the ABC superfamily of eukaryotic origin, such as P-glycoprotein (19) and MRP1 (21).”
BackgroundInfluentialATP-dependent Transport of Bile Salts by Rat Multidrug Resistance-associated Protein 3 (Mrp3)
Hirohashi, T., Suzuki, H., Takikawa, H., & Sugiyama, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2905 · Cited by 338
Natural products as multidrug resistance modulators in cancer
Kumar, A., & Jaitak, V. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.027 · Cited by 334
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
GILLET, J., EFFERTH, T., & REMACLE, J. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.05.002 · Cited by 337
Allikmets, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.10.1649 · Cited by 334
“In the case of the CFTR/MRP subfamily, the N- and C-terminal domains of the different proteins cluster together but are significantly diverged from one another as shown previously ( 14 ,37).”
BackgroundIntestinal drug transporters: An overview
Estudante, M., Morais, J. G., Soveral, G., & Benet, L. Z. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.042 · Cited by 330
Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.
Komatsu, M., Sumizawa, T., Mutoh, M., Chen, Z., Terada, K., Furukawa, T., Yang, X., Gao, H., Miura, N., Sugiyama, T., et al. (2000) · PubMed · Cited by 328
Expression of members of the multidrug resistance protein family in human term placenta
St-Pierre, M. V., Serrano, M. A., Macias, R. I. R., Dubs, U., Hoechli, M., Lauper, U., Meier, P. J., & Marin, J. J. G. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.4.r1495 · Cited by 325
Saurin, W., Hofnung, M., & Dassa, E. (1999) · Journal of Molecular Evolution · doi:10.1007/pl00006442 · Cited by 323
Interactions of the Human Multidrug Resistance Proteins MRP1 and MRP2 with Organic Anions
Bakos, É., Evers, R., Sinkó, E., Váradi, A., Borst, P., & Sarkadi, B. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26477-4 · Cited by 322
“The human multidrug resistance proteins 1 and 2 [MRP1 and MRP2 (multispecific organic anion transporter), respectively] are homologous members of a subfamily of the ATPbinding cassette transporters, and both may cause multiple drug resistance in malignant tumor cells (Cole et al., 1992; Zaman et al., 1994; Cui et al.,…”
Multidrug Resistance Proteins (MRPs, ABCCs): Importance for Pathophysiology and Drug Therapy
Keppler, D. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_8 · Cited by 318
Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology
Ballatori, N., Krance, S. M., Marchan, R., & Hammond, C. L. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.004 · Cited by 318
“Evidence for GSH transport on Mrp1, Mrp2, Mrp4, Mrp5, and Cftr, and proposed transport mechanisms MRP1 was cloned in 1992 from the human small cell lung cancer cell line H69 that had been repeatedly exposed to doxorubicin, an anthracyclin (Cole et al., 1992).”
BackgroundNorris, M. D., Bordow, S. B., Marshall, G. M., Haber, P. S., Cohn, S. L., & Haber, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340405 · Cited by 322
Kikuchi, T., Daigo, Y., Katagiri, T., Tsunoda, T., Okada, K., Kakiuchi, S., Zembutsu, H., Furukawa, Y., Kawamura, M., Kobayashi, K., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206288 · Cited by 317
“Additionally, members of the MRP family of transporters (Cole et al., 1992) are thought to play important roles in immortalization of cancer cells and in metabolism of anti-cancer drugs.”
BackgroundAdministration, distribution, metabolism and elimination of polymer therapeutics
Markovsky, E., Baabur-Cohen, H., Eldar-Boock, A., Omer, L., Tiram, G., Ferber, S., Ofek, P., Polyak, D., Scomparin, A., & Satchi-Fainaro, R. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.021 · Cited by 313
“Overexpression of the ATP-binding cassette (ABC) transporters, mainly P-glycoprotein (Pgp) [126], multidrug resistance-associated proteins (MRP) [127] and breast cancer resistance proteins (BCRP) [128], is one of the primary mechanisms of MDR.”
BackgroundJasiński, M., Stukkens, Y., Degand, H., Purnelle, B., Marchand-Brynaert, J., & Boutry, M. (2001) · The Plant Cell · doi:10.1105/tpc.13.5.1095 · Cited by 311
“In mammals, the MRPs HmMRP1 (Cole et al., 1992) and cMOAT (Buchler et al.”
BackgroundZELCER, N., REID, G., WIELINGA, P., KUIL, A., van der HEIJDEN, I., SCHUETZ, J. D., & BORST, P. (2003) · Biochemical Journal · doi:10.1042/bj20021886 · Cited by 281
Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and Future
Cole, S. P. C. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135959 · Cited by 309
Self-citationZhang, S., & Morris, M. E. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044412 · Cited by 309
“Western Analysis of P-gp and MRP1.”
BackgroundMethodInfluentialFROM VACUOLAR GS-X PUMPS TO MULTISPECIFIC ABC TRANSPORTERS
Rea, P. A., Li, Z.-S., Lu, Y.-P., Drozdowicz, Y. M., & Martinoia, E. (1998) · Annual Review of Plant Physiology and Plant Molecular Biology · doi:10.1146/annurev.arplant.49.1.727 · Cited by 306
Drug efflux transporters in the CNS
Sun, H., Dai, H., Shaik, N., & Elmquist, W. F. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00172-2 · Cited by 304
Multidrug resistance associated proteins in multidrug resistance
Sodani, K., Patel, A., Kathawala, R. J., & Chen, Z.-S. (2012) · Chinese Journal of Cancer · doi:10.5732/cjc.011.10329 · Cited by 300
JEDLITSCHKY, G., LEIER, I., BUCHHOLZ, U., HUMMEL-EISENBEISS, J., BURCHELL, B., & KEPPLER, D. (1997) · Biochemical Journal · doi:10.1042/bj3270305 · Cited by 303
Molecular aspects of hepatobiliary transport
Muller, M., & Jansen, P. L. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.6.g1285 · Cited by 299
ABC transporters in lipid transport
Borst, P., Zelcer, N., & van Helvoort, A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00053-6 · Cited by 300
“The multidrug resistance (-associated) protein MRP1 was discovered in 1992 [21,22] and ¢ve additional family members, MRP2^6, have been described since [23^25].”
ABC-transporters: implications on drug resistance from microorganisms to human cancers
Lage, H. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00203-6 · Cited by 298
“The second major ABC-transporter involved in MDR of human cancers was described in 1992 [107].”
BackgroundAssessment of viability of microorganisms employing fluorescence techniques
Breeuwer, P., & Abee, T. (2000) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(00)00163-x · Cited by 299
Riganti, C., Miraglia, E., Viarisio, D., Costamagna, C., Pescarmona, G., Ghigo, D., & Bosia, A. (2005) · Cancer Research · doi:10.1158/0008-5472.516.65.2 · Cited by 271
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
Dallas, S., Miller, D. S., & Bendayan, R. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.3 · Cited by 296
“It has been 14 years since Cole and Deeley cloned the first MRP transporter, MRP1 (Cole et al., 1992).”
BackgroundDelivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain
Agarwal, S., Sane, R., Oberoi, R., Ohlfest, J. R., & Elmquist, W. F. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001888 · Cited by 292
Kage, K., Tsukahara, S., Sugiyama, T., Asada, S., Ishikawa, E., Tsuruo, T., & Sugimoto, Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10100 · Cited by 291
Burger, H., Foekens, J. A., Look, M. P., Gelder, M. E. M., Klijn, J. G. M., Wiemer, E. A. C., Stoter, G., & Nooter, K. (2003) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 341
LEIER, I., JEDLITSCHKY, G., BUCHHOLZ, U., CENTER, M., COLE, S. P. C., DEELEY, R. G., & KEPPLER, D. (1996) · Biochemical Journal · doi:10.1042/bj3140433 · Cited by 291
Self-citationSoroka, C. J., Lee, J. M., Azzaroli, F., & Boyer, J. L. (2001) · Hepatology · doi:10.1053/jhep.2001.23501 · Cited by 288
Substrate recognition and transport by multidrug resistance protein 1 (ABCC1)
Deeley, R. G., & Cole, S. P. C. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.036 · Cited by 284
“MRP1 mRNA levels were elevated approximately 100-fold [1].”
BackgroundSelf-citationLu, Y.-P., Li, Z.-S., & Rea, P. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8243 · Cited by 282
Intracellular pH and the control of multidrug resistance.
Simon, S., Roy, D., & Schindler, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1128 · Cited by 276
Lu, Y.-P., Li, Z.-S., Drozdowicz, Y. M., Hörtensteiner, S., Martinoia, E., & Rea, P. A. (1998) · The Plant Cell · doi:10.1105/tpc.10.2.267 · Cited by 278
“AtMRP1 is both a structural and functional homolog of the human multidrug resistance–associated protein ( HmMRP1 ) gene product (Cole et al., 1992), which has been identified on the basis of its ability to confer GS conjugate pump activity on transfected cells (Leier et al., 1 These authors contributed equally to this…”
BackgroundInfluentialModulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
Sikic, B. I. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051055 · Cited by 277
“A non-Pgp membrane transporter termed the multidrug-resistance-associated protein (MRP) has been identified, and its gene sequenced in a doxorubicin-selected lung cancer cell line [18].”
The Effect of Rifampin Treatment on Intestinal Expression of Human MRP Transporters
Fromm, M. F., Kauffmann, H.-M., Fritz, P., Burk, O., Kroemer, H. K., Warzok, R. W., Eichelbaum, M., Siegmund, W., & Schrenk, D. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64794-3 · Cited by 277
“12 MRP2, which is also termed canalicular multispecific organic anion transporter (cMOAT) is predominantly expressed at the biliary pole of hepatocytes, but has also been found in the apical brush-border membrane of proximal tubules in the kidney.”
BackgroundKlein, M., Burla, B., & Martinoia, E. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.11.056 · Cited by 275
“Multidrug resistance-associated proteins (MRPs) were originally identified in drug-resistant human lung cancer cell lines (HsMRP1; ABCC1, [1]).”
BackgroundFlavonoid–drug interactions: Effects of flavonoids on ABC transporters
Morris, M. E., & Zhang, S. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.003 · Cited by 273
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases
Chen, Z., & Tiwari, A. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08235.x · Cited by 274
“MRP1 (gene symbol ABCC1) was the first of the drug transporting ABCC proteins to be cloned and was found to be highly overexpressed in a doxorubicin-selected multidrug resistant human lung carcinoma cell line H69AR [2].”
BackgroundMolecular Mechanisms of Treatment Resistance in Glioblastoma
Ou, A., Yung, W. K. A., & Majd, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010351 · Cited by 269
ATP-dependent 17β-Estradiol 17-(β-D-Glucuronide) Transport by Multidrug Resistance Protein (MRP)
Loe, D. W., Almquist, K. C., Cole, S. P. C., & Deeley, R. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9683 · Cited by 267
Self-citationTissue Distribution and Induction of Human Multidrug Resistant Protein 3
Scheffer, G. L., Kool, M., de Haas, M., de Vree, J. M. L., Pijnenborg, A. C. L. M., Bosman, D. K., Oude Elferink, R. P. J., van der Valk, P., Borst, P., & Scheper, R. J. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780411 · Cited by 266
“Until recently, only MRP1 and MRP2 were shown to confer resistance to a wide variety of chemotherapeutic agents in human cancer cells (Cole and Deeley, 1998; Cole et al, 1992; Cui et al, 1999; Evers et al, 2000).”
BackgroundIshikawa, T., Bao, J.-J., Yamane, Y., Akimaru, K., Frindrich, K., Wright, C. D., & Kuo, M. T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14981 · Cited by 266
Defective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy
Altan, N., Chen, Y., Schindler, M., & Simon, S. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1583 · Cited by 265
“These include changes in the type and amount of cellular lipids and in the expression of proteins, including P-glycoprotein (Pgp) (3, 4), MDR-associated protein (MRP) (5), glutathione S -transferase (6), protein kinase C (7), DNA topoisomerase II (8), and the vacuolar proton ATPase (9).”
BackgroundInfluentialClinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance
Xiao, H., Zheng, Y., Ma, L., Tian, L., & Sun, Q. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.648407 · Cited by 263
“ABCC1 ABCC1 transporter is encoded by ABCC1 gene, with the weight of 190 kDa and contains 1580 amino acids (Cole et al., 1992).”
Background
Metadata
- Authors
- Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G.
- Affiliations
- Queen's University (CA)
- Venue
- Science
- Published
- 1992-12-04
- Volume
- 258
- Issue
- 5088
- Pages
- 1650-1654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2168070336
- Cited by
- 3,037
- References
- 47
- Citations by year
- 2026: 12 · 2025: 30 · 2024: 46 · 2023: 55 · 2022: 40 · 2021: 53 · 2020: 61 · 2019: 39 · 2018: 45 · 2017: 55 · 2016: 66 · 2015: 67 · 2014: 79 · 2013: 80 · 2012: 77
- FWCI
- 37.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- multidrug resistance, lung cancer, doxorubicin resistance, ABC transporters, gene amplification, P-glycoprotein, mRNA overexpression, cDNA cloning
- MeSH terms
- Amino Acid Sequence, Animals, Chromosome Banding, Chromosomes, Human, Pair 16, Doxorubicin, Drug Resistance, Gene Amplification, Multigene Family, Humans, Lung, Lung Neoplasms, Male, Membrane Glycoproteins, Molecular Sequence Data, Phylogeny, RNA, Messenger, Testis, Tumor Cells, Cultured, Sequence Homology, Amino Acid, ATP Binding Cassette Transporter, Subfamily B, Member 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.